| |
Epigenetics: Unwrapping the Future for Drug
Discovery?
Thursday, October 20, 2011
Bentley
University
Waltham, Massachusetts
Registration is now closed
If you have not yet paid for your
registration, visit this link.
Program
|
8:00-9:00
|
Check-in, Light breakfast, / Exhibitor setup |
|
9:00-9:10
|
Opening Remarks
Rajvi Chopra, Novartis |
|
Session I
|
Chair: Sharon Townson |
|
9:10-9:55
|
"Defining the Cancer Epigenome and its Potential for Therapeutic
Targeting"
Stephen Baylin, The John Hopkins University - School of Medicine |
|
9:55-10:30
|
"Protein Methyltransferase Inhibitors as Personalized Cancer
Therapeutics"
Robert Copeland, Epizyme |
|
10:30-11:00
|
Coffee |
|
Session II
|
Chair: Nessa Carey |
|
11:00-11:35
|
"The Intersection of Structural Biology and Epigenetics"
Steve Bellon, Constellation Pharmaceuticals |
|
11:35-12:20
|
"Structural and chemical biology of readers and writers of the
histone code"
Cheryl Arrowsmith, SGC - Toronto |
|
12:20-1:10
|
Lunch |
|
Session III
|
Chair: Elizabeth Sprague |
|
1:10-1:55
|
"Mechanisms for Coordinated DNA Methylation and Histone
Methylation"
Xiaodong Cheng, Emory University School of Medicine |
|
1:55-2:30
|
"Chemical Inhibition of Bromodomains"
James Bradner, Dana Farber Cancer Institute / HMS |
|
2:30-3:00
|
Coffee |
|
Session IV
|
Chair: Steven Kazmirski |
|
3:00-3:35
|
"Molecular recognition of nucleosomes by chromatin factors and
enzymes"
Song Tan, Penn State University |
|
3:35-4:10
|
"Structural Basis of Substrate Methylation and Inhibition of
SMYD2"
Andrew Ferguson, AstraZeneca |
|
4:10-4:45
|
"Epigenetic therapies in non-oncology indications - the
opportunities and the challenges"
Nessa Carey, Pfizer UK |
|
4:45
|
Mixer |
Organizing Committee
Check back for more information
Meeting Sponsors
Registration is now closed
|
